结直肠癌CT和MRI标注专家共识(2020)

2021-02-28 中华医学会放射学分会 中华放射学杂志.2021.55(2):111-116.

结直肠癌是临床最常见的恶性肿瘤之一。将人工智能应用于结直肠癌,有助于辅助检出和诊断病变、评估疗效和预后并进行随访等,从而使患者受益。为了规范结直肠癌数据标注,促进人工智能更好地落地临床,中华医学会放射

中文标题:

结直肠癌CT和MRI标注专家共识(2020)

发布日期:

2021-02-28

简要介绍:

结直肠癌是临床最常见的恶性肿瘤之一。将人工智能应用于结直肠癌,有助于辅助检出和诊断病变、评估疗效和预后并进行随访等,从而使患者受益。为了规范结直肠癌数据标注,促进人工智能更好地落地临床,中华医学会放射学分会大数据与人工智能工作委员会、中华医学会放射学分会腹部学组和磁共振学组联合编写结直肠癌CT和MRI标注专家共识,从结直肠癌的定义和影像表现、标注类别和方法、注意事项、标注原则、标注要求、标注人员要求及流程等各个方面达成的共识,有助于提高数据标注的一致性,进而建立鲁棒性好、泛化能力强的人工智能算法模型,提升结直肠癌诊疗水平。

下载附件:

(因为版权问题,不支持下载)

评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1055332, encodeId=dcc4105533229, content=有用!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6b1307344, createdName=xuxin72722, createdTime=Mon Sep 27 13:27:16 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974737, encodeId=04d69e4737f1, content=值得拥有,点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Fri Jun 18 21:51:08 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974736, encodeId=511f9e4736f6, content=对日常工作非常有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Fri Jun 18 21:48:24 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974314, encodeId=0dc79e4314e4, content=值得收藏,很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Thu Jun 17 09:58:01 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974305, encodeId=d35d9e430582, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Thu Jun 17 09:47:57 CST 2021, time=2021-06-17, status=1, ipAttribution=)]
    2021-09-27 xuxin72722

    有用!

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1055332, encodeId=dcc4105533229, content=有用!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6b1307344, createdName=xuxin72722, createdTime=Mon Sep 27 13:27:16 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974737, encodeId=04d69e4737f1, content=值得拥有,点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Fri Jun 18 21:51:08 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974736, encodeId=511f9e4736f6, content=对日常工作非常有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Fri Jun 18 21:48:24 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974314, encodeId=0dc79e4314e4, content=值得收藏,很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Thu Jun 17 09:58:01 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974305, encodeId=d35d9e430582, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Thu Jun 17 09:47:57 CST 2021, time=2021-06-17, status=1, ipAttribution=)]
    2021-06-18 1205446bm69(暂无昵称)

    值得拥有,点赞

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1055332, encodeId=dcc4105533229, content=有用!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6b1307344, createdName=xuxin72722, createdTime=Mon Sep 27 13:27:16 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974737, encodeId=04d69e4737f1, content=值得拥有,点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Fri Jun 18 21:51:08 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974736, encodeId=511f9e4736f6, content=对日常工作非常有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Fri Jun 18 21:48:24 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974314, encodeId=0dc79e4314e4, content=值得收藏,很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Thu Jun 17 09:58:01 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974305, encodeId=d35d9e430582, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Thu Jun 17 09:47:57 CST 2021, time=2021-06-17, status=1, ipAttribution=)]
    2021-06-18 1205446bm69(暂无昵称)

    对日常工作非常有帮助

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1055332, encodeId=dcc4105533229, content=有用!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6b1307344, createdName=xuxin72722, createdTime=Mon Sep 27 13:27:16 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974737, encodeId=04d69e4737f1, content=值得拥有,点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Fri Jun 18 21:51:08 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974736, encodeId=511f9e4736f6, content=对日常工作非常有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Fri Jun 18 21:48:24 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974314, encodeId=0dc79e4314e4, content=值得收藏,很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Thu Jun 17 09:58:01 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974305, encodeId=d35d9e430582, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Thu Jun 17 09:47:57 CST 2021, time=2021-06-17, status=1, ipAttribution=)]
    2021-06-17 1205446bm69(暂无昵称)

    值得收藏,很棒

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1055332, encodeId=dcc4105533229, content=有用!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=af6b1307344, createdName=xuxin72722, createdTime=Mon Sep 27 13:27:16 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974737, encodeId=04d69e4737f1, content=值得拥有,点赞, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Fri Jun 18 21:51:08 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974736, encodeId=511f9e4736f6, content=对日常工作非常有帮助, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Fri Jun 18 21:48:24 CST 2021, time=2021-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974314, encodeId=0dc79e4314e4, content=值得收藏,很棒, beContent=null, objectType=guider, channel=null, level=null, likeNumber=72, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Thu Jun 17 09:58:01 CST 2021, time=2021-06-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=974305, encodeId=d35d9e430582, content=很实用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210925/90bb8e5e1e1549578d7e5dcf0325e6a7/6833dbcc30864cabb97fe04f83406e9a.jpg, createdBy=389d2172044, createdName=1205446bm69(暂无昵称), createdTime=Thu Jun 17 09:47:57 CST 2021, time=2021-06-17, status=1, ipAttribution=)]
    2021-06-17 1205446bm69(暂无昵称)

    很实用

    0

拓展阅读

2010 BSG 中高危人群结直肠癌筛查与监测指南

英国胃肠病学会(BSG,British Society of Gastroenterology) · 2010-05-01

2010 结直肠癌肝转移诊断和综合治疗指南(V 2010)

中华医学会外科学分会 · 2010-06-01

2011 NICE 结直肠癌诊疗指南

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-01-01

2011NICE 结直肠癌高危人群(溃疡性结肠炎、克罗恩病、结直肠腺瘤患者)结肠镜监测指南

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2011-03-23

2011 规范结直肠癌术中缓释型氟尿嘧啶腹腔内化疗的专家共识

结直肠癌术中缓释型氟尿嘧啶腹腔内化疗共识专家组 · 2011-06-01

结直肠癌诊疗规范(2010年版)

中华人民共和国卫生部(MINISTRY OF HEALTH OF THE PEOPLE`S REPUBLIC OF CHINA) · 2011-12-20